UB Paderborn / Katalog / Suche / in CDI

1 – 22 von 22

Sortiert nach

Editorial: The utilization of bench-to-bedside approaches in pharmacogenomics

Frontiers in pharmacology, 2023-06, Vol.14, p.1234219-1234219

2023

Volltextzugriff (PDF)

Predictive capability of Cys112Arg single nucleotide polymorphisms of the apolipoprotein E gene in assessing the risk of immediate and early post-traumatic seizures

Terapevtic̆eskii arhiv, 2023-12, Vol.95 (12), p.1128

2023

Volltextzugriff (PDF)

CRT-500.17 Esmolol Facilitates Prolonged Conduction Preservation in the Ex Vivo Heart Studies

JACC. Cardiovascular interventions, 2023-02, Vol.16 (4), p.S72-S73

2023

Volltextzugriff (PDF)

Comprehensive Analysis of Anticoagulant Therapy in Patients with Isolated Atrial Flutter

The American journal of cardiology, 2024-07

2024

Volltextzugriff (PDF)

Esmolol Facilitates Prolonged Conduction Preservation in the Ex Vivo Heart Studies

Cardiovascular revascularization medicine, 2023-08, Vol.53, p.S87-S88

2023

Volltextzugriff (PDF)

Endovascular occlusion of patent foramen ovale as antiarrhythmic treatment of atrial fibrillation

Journal of interventional cardiac electrophysiology, 2024-07

2024

Volltextzugriff (PDF)

CRT-100.25 MicroRNAs as Novel Biomarkers to Guide DAPT After PCI – Preliminary Assessment

JACC. Cardiovascular interventions, 2023-02, Vol.16 (4), p.S14-S14

2023

Volltextzugriff (PDF)

A Sewing Approach to the Fabrication of Eco/bioresorbable Electronics

Small (Weinheim an der Bergstrasse, Germany), 2023-12, Vol.19 (49), p.e2305017-n/a

2023

Volltextzugriff (PDF)

A Sewing Approach to the Fabrication of Eco/bioresorbable Electronics (Small 49/2023)

Small (Weinheim an der Bergstrasse, Germany), 2023-12, Vol.19 (49), p.n/a

2023

Volltextzugriff (PDF)

MicroRNAs as Novel Biomarkers to Guide DAPT After PCI – Preliminary Assessment

Cardiovascular revascularization medicine, 2023-08, Vol.53, p.S25

2023

Volltextzugriff (PDF)

Sympathetic remodeling and altered angiotensin-converting enzyme 2 localization occur in patients with cardiac disease but are not exacerbated by severe COVID-19

Autonomic neuroscience, 2024-02, Vol.251, p.103134-103134, Article 103134

2024

Volltextzugriff (PDF)

An Intracardiac Soft Robotic Device for Augmentation of Blood Ejection from the Failing Right Ventricle

Annals of biomedical engineering, 2017-09, Vol.45 (9), p.2222-2233

2017

Volltextzugriff (PDF)

Soft, bioresorbable, transparent microelectrode arrays for multimodal spatiotemporal mapping and modulation of cardiac physiology

Science advances, 2023-07, Vol.9 (27), p.eadi0757-eadi0757

2023

Volltextzugriff (PDF)

MicroRNAs as Novel Biomarkers for P2Y12 - Inhibitors Resistance Prediction

Pharmacogenomics and personalized medicine, 2021-01, Vol.14, p.1575-1582

2021

Volltextzugriff (PDF)

CRT-100.09 The Impact of CYP2C19, ABCB1 Genes Polymorphisms and CYP3A4 Isoenzyme Activity on the Incidence of Stent Implantation Complications for Patients With an Acute Coronary Syndrome

JACC. Cardiovascular interventions, 2017-02, Vol.10 (3), p.S6-S6

2017

Volltextzugriff (PDF)

Clinically relevant pharmacogenetic markers in Tatars and Balkars

Molecular biology reports, 2020-05, Vol.47 (5), p.3377-3387

2020

Volltextzugriff (PDF)

Do CYP2C19 and ABCB1 gene polymorphisms and low CYP3A4 isoenzyme activity have an impact on stent implantation complications in acute coronary syndrome patients?

Pharmacogenomics and personalized medicine, 2020-03, p.243

2020

Volltextzugriff (PDF)

Do CYP2C19 and ABCB1 gene polymorphisms and low CYP3A4 isoenzyme activity have an impact on stent implantation complications in acute coronary syndrome patients?

Pharmacogenomics and personalized medicine, 2017-01, Vol.10, p.243-245

2017

Volltextzugriff (PDF)

Do CYP2C19 andABCB1 gene polymorphisms and low CYP3A4 isoenzyme activity have an impact on stent implantation complications in acute coronary syndrome patients?

Pharmacogenomics and personalized medicine, 2017-01, Vol.10, p.243

2017

Volltextzugriff (PDF)

Do CYP2C 19 and ABCB1 gene polymorphisms and low CYP3A4 isoenzyme activity have an impact on stent implantation complications in acute coronary syndrome patients?(ORIGINAL RESEARCH)(cytochrome p-450)

Pharmacogenomics and personalized medicine, 2017-01, Vol.10, p.243

2017

Volltextzugriff (PDF)

MicroRNAs as novel biomarkers for rivaroxaban therapeutic drug monitoring

Drug metabolism and personalized therapy, 2021-08, Vol.37 (1), p.41

2021

Volltextzugriff (PDF)

The ABCB1, CYP2C19, CYP3A5 and CYP4F2 genetic polymorphisms and platelet reactivity in the early phases of acute coronary syndromes

Drug metabolism and personalized therapy, 2018-09, Vol.33 (3), p.109

2018

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(22)

Sprache

Englisch
(22)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(10)
Humans
(7)
Life Sciences & Biomedicine
(7)
Acute Coronary Syndrome
(3)
Biomarkers
(3)
Blood Platelets
(3)
Cytochrome P-450
(3)
Female
(3)
Genetic Polymorphisms
(3)
Heart Diseases
(3)
Pharmacology & Pharmacy
(3)
Polymorphism
(3)
Absorbable Implants
(2)
Acute Coronary Syndromes
(2)
Aggregation
(2)
Analysis
(2)
Angioplasty
(2)
Animals
(2)
Atp Binding Cassette Transporter, Subfamily B - Genetics
(2)
Atrial Fibrillation
(2)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Editorial: The utilization of bench-to-bedside approaches in pharmacogenomics

Predictive capability of Cys112Arg single nucleotide polymorphisms of the apolipoprotein E gene in assessing the risk of immediate and early post-traumatic seizures

CRT-500.17 Esmolol Facilitates Prolonged Conduction Preservation in the Ex Vivo Heart Studies

Comprehensive Analysis of Anticoagulant Therapy in Patients with Isolated Atrial Flutter

Esmolol Facilitates Prolonged Conduction Preservation in the Ex Vivo Heart Studies

Endovascular occlusion of patent foramen ovale as antiarrhythmic treatment of atrial fibrillation

CRT-100.25 MicroRNAs as Novel Biomarkers to Guide DAPT After PCI – Preliminary Assessment

A Sewing Approach to the Fabrication of Eco/bioresorbable Electronics

A Sewing Approach to the Fabrication of Eco/bioresorbable Electronics (Small 49/2023)

MicroRNAs as Novel Biomarkers to Guide DAPT After PCI – Preliminary Assessment

Sympathetic remodeling and altered angiotensin-converting enzyme 2 localization occur in patients with cardiac disease but are not exacerbated by severe COVID-19

An Intracardiac Soft Robotic Device for Augmentation of Blood Ejection from the Failing Right Ventricle

Soft, bioresorbable, transparent microelectrode arrays for multimodal spatiotemporal mapping and modulation of cardiac physiology

MicroRNAs as Novel Biomarkers for P2Y12 - Inhibitors Resistance Prediction

CRT-100.09 The Impact of CYP2C19, ABCB1 Genes Polymorphisms and CYP3A4 Isoenzyme Activity on the Incidence of Stent Implantation Complications for Patients With an Acute Coronary Syndrome

Clinically relevant pharmacogenetic markers in Tatars and Balkars

Do CYP2C19 and ABCB1 gene polymorphisms and low CYP3A4 isoenzyme activity have an impact on stent implantation complications in acute coronary syndrome patients?

Do CYP2C19 and ABCB1 gene polymorphisms and low CYP3A4 isoenzyme activity have an impact on stent implantation complications in acute coronary syndrome patients?

Do CYP2C19 andABCB1 gene polymorphisms and low CYP3A4 isoenzyme activity have an impact on stent implantation complications in acute coronary syndrome patients?

Do CYP2C 19 and ABCB1 gene polymorphisms and low CYP3A4 isoenzyme activity have an impact on stent implantation complications in acute coronary syndrome patients?(ORIGINAL RESEARCH)(cytochrome p-450)

MicroRNAs as novel biomarkers for rivaroxaban therapeutic drug monitoring

The ABCB1, CYP2C19, CYP3A5 and CYP4F2 genetic polymorphisms and platelet reactivity in the early phases of acute coronary syndromes

Suchergebnisse filtern